The 3rd annual edition will focus upon the operational challenges in clinical development found within Germany, Austria and Switzerland. Over 2 days, delegates will discuss the common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivising good relationships with CROs and constructing defined deadlines.
- Focused conference for the DACH pharma market– Unlike other conferences, our event specifically focuses on the local pharma industry in Switzerland, Germany and Austria, highlighting the current challenges and exciting innovations and opportunities within the market
- Excellent speaker line up – Senior level speakers from leading organisations such as Roche, Janssen and Celgene along with exciting biotechs like Medac and Medigene
- Great and Diverse Sessions – Our OCT DACH covers a variety of topics ranging from COVID-19 updates to Direct to Patient and Data management innovation to CRO relationship
- Unbeatable Networking Opportunities – Meet and network with over 150 senior industry decision makers during our dedicated networking breaks, round tables and interactive sessions